Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01241721 · ClinicalTrials.gov registry record · NA
Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer
A NA study of Breast Cancer and Breast Cancer Surgery, sponsored by Swedish Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
- 2
- Study locations
NCT01241721 is a NA study of Breast Cancer and Breast Cancer Surgery that has completed, run by Swedish Medical Center. The registered enrollment target is 34 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01241721, a NA study of Breast Cancer and Breast Cancer Surgery, has completed, sponsored by Swedish Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine the optimal, lowest dose of radioactive tracer required for Positron Emission Mammography (PEM), and the accuracy and reliability of PEM in pre-surgical evaluations for patients with newly diagnosed breast cancer anticipating breast-conserving surgery but identified to have a second unsuspected breast cancer by MRI.
Conditions Studied
Interventions
- DEVICE Positron Emission Mammography (PEM)
Study Locations (2)
Washington
- Swedish Cancer Institute - Seattle
- Swedish Cancer Institute Cherry Hill Campus - Comprehensive Breast Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-09 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01241721
The ClinicalTrials.gov registry entry for NCT01241721 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Positron Emission Mammography (PEM) is the first listed.
NCT01241721 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01241721 about?
NCT01241721 is a clinical study titled "Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer". The purpose of the study is to determine the optimal, lowest dose of radioactive tracer required for Positron Emission Mammography (PEM), and the accuracy and reliability of PEM in pre-surgical evaluations for patients with newly diagnosed breast cancer anticipating breast-conserving surgery but ide...
What is the current status of trial NCT01241721?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2010-09. Estimated completion is 2016-04.
What conditions does trial NCT01241721 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Surgery.
What interventions are being tested in trial NCT01241721?
The interventions under investigation include: Positron Emission Mammography (PEM) (DEVICE).
Who is sponsoring clinical trial NCT01241721?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01241721 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.